1. Home
  2. SSL vs HAE Comparison

SSL vs HAE Comparison

Compare SSL & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sasol Ltd.

SSL

Sasol Ltd.

HOLD

Current Price

$6.50

Market Cap

3.8B

Sector

Energy

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$80.26

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSL
HAE
Founded
1950
1971
Country
South Africa
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.7B
IPO Year
N/A
1991

Fundamental Metrics

Financial Performance
Metric
SSL
HAE
Price
$6.50
$80.26
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$88.38
AVG Volume (30 Days)
769.7K
712.4K
Earning Date
02-23-2026
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
42.54
EPS
0.59
3.44
Revenue
$14,028,282,389.00
$1,327,850,000.00
Revenue This Year
$0.47
N/A
Revenue Next Year
$5.51
$6.01
P/E Ratio
$10.82
$23.33
Revenue Growth
N/A
N/A
52 Week Low
$2.78
$47.32
52 Week High
$7.39
$87.32

Technical Indicators

Market Signals
Indicator
SSL
HAE
Relative Strength Index (RSI) 54.69 56.20
Support Level $6.36 $79.41
Resistance Level $6.47 $80.94
Average True Range (ATR) 0.13 1.74
MACD 0.04 -0.93
Stochastic Oscillator 81.73 19.45

Price Performance

Historical Comparison
SSL
HAE

About SSL Sasol Ltd.

Sasol Ltd operates as a vertically integrated chemicals and energy company through its two main businesses: the Southern Africa Energy & Chemicals business and the International Chemical business. It generates maximum revenue from the Southern Africa Energy & Chemicals business, which operates integrated value chains with feedstock sourced from the Mining and Gas operating segments. Geographically, the company generates the majority of its revenue from South Africa.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: